Funder: [National Institutes of Health - https://www.nih.gov]
Due Dates: January 28, 2025 (Letter of Intent) | February 28, 2025 (Application) | March 1, 2025 (Expiration)
Funding Amounts: Up to $1 million direct costs per year | Project period up to 5 years | 3-4 awards expected totaling $6 million in FY 2025
Summary: Supports applications applying AI/ML methods to accelerate preclinical drug discovery and development for Alzheimer's disease and related dementias, including creation of open-source tools.
Key Information: Clinical trials are not allowed under this FOA; encourages collaborations between academia and industry; strong emphasis on open science and data sharing.